Subjective cognitive decline domain improves accuracy of plasma Aβ42/Aβ40 for preclinical Alzheimer's disease diagnosis: The SILCODE study

• Mingkai Zhang,
• Xiaoni Wang,
• Weina Zhao,
• Yuxia Li,
• Chao Ying,
• Jiehui Jiang,
• Yanning Cai,
• Jie Lu,
• Ying Han,
• Ting Gao,
• Xiuyuan Hao

Affiliations

Mingkai Zhang

1 Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China

Xiaoni Wang

2 Department of Neurology, Sir Run Run Shaw Hospital, Affiliated with School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China

Weina Zhao

3 Department of Neurology, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, China

Yuxia Li

5 Department of Neurology, Tangshan Central Hospital, Tangshan, Hebei 063000, China

Chao Ying

6 Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of the Ministry of Education, Beijing 100053, China

Jiehui Jiang

7 Institute for Advanced Communication and Data Science, Shanghai University, Shanghai 200444, China

Yanning Cai

6 Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of the Ministry of Education, Beijing 100053, China

Jie Lu

8 Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

Ying Han

1 Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China

Ting Gao

Xiuyuan Hao